Dolby Laboratories (DLB) Change in Accured Expenses (2009 - 2026)

Dolby Laboratories (DLB) has 18 years of Change in Accured Expenses data on file, last reported at -$47.3 million in Q2 2026.

• Quarterly Change in Accured Expenses rose 38.01% year-over-year to -$47.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $107.4 million (up 4085.2% YoY) and the FY2025 annual result came in at $22.9 million, up 166.13% from the prior year.
• Change in Accured Expenses retreated to -$47.3 million in Q2 2026, from $39.3 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $71.8 million in Q3 2025 to a low of -$105.3 million in Q2 2023.
• A 5-year average of -$1.6 million and a median of $6.7 million in 2022 frame the typical range for Change in Accured Expenses.
• The widest YoY moves for Change in Accured Expenses: up 935.69% in 2023, down 1469.91% in 2023.
• Tracing DLB's Change in Accured Expenses over 5 years: stood at $5.8 million in 2022, then sank by 654.95% to -$32.0 million in 2023, then surged by 115.02% to $4.8 million in 2024, then soared by 807.06% to $43.6 million in 2025, then tumbled by 208.46% to -$47.3 million in 2026.
• The last three Change in Accured Expenses figures came in at -$47.3 million (Q2 2026), $39.3 million (Q1 2026), and $43.6 million (Q4 2025), per Business Quant data.